Refractory Seizures Associated With Tuberous Sclerosis Complex clinical trials

Explore recruiting refractory seizures associated with tuberous sclerosis complex clinical trials.

Also recruiting in Europe

Refractory Seizures Associated With Tuberous Sclerosis Complex trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open-label, multi-center long-term safety roll-over study in patients with tuberous sclerosis complex (TSC) and refractory seizures who are judged by the Investigator to benefit from continued treatment with everolimus after completion of Study CRAD001M2304 (EXIST-3)

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Refractory Seizures Associated With Tuberous Sclerosis Complex trials by city

Refractory Seizures Associated With Tuberous Sclerosis Complex in Toronto Refractory Seizures Associated With Tuberous Sclerosis Complex in Vancouver Refractory Seizures Associated With Tuberous Sclerosis Complex in Montreal Refractory Seizures Associated With Tuberous Sclerosis Complex in Calgary Refractory Seizures Associated With Tuberous Sclerosis Complex in Edmonton Refractory Seizures Associated With Tuberous Sclerosis Complex in Ottawa Refractory Seizures Associated With Tuberous Sclerosis Complex in Winnipeg Refractory Seizures Associated With Tuberous Sclerosis Complex in Quebec City Refractory Seizures Associated With Tuberous Sclerosis Complex in Hamilton Refractory Seizures Associated With Tuberous Sclerosis Complex in Kitchener Refractory Seizures Associated With Tuberous Sclerosis Complex in London Refractory Seizures Associated With Tuberous Sclerosis Complex in Halifax Refractory Seizures Associated With Tuberous Sclerosis Complex in New York Refractory Seizures Associated With Tuberous Sclerosis Complex in Los Angeles Refractory Seizures Associated With Tuberous Sclerosis Complex in Chicago Refractory Seizures Associated With Tuberous Sclerosis Complex in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease